throbber
(I 2) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT)
`
`(19) World Intellectual Property Organization
`International Bureau
`
`(43) International Publication Date
`19 April 2007 (19.04.2007)
`
`(51) International Patent Classification:
`A01N 37/10 (2006.01)
`
`(21) International Application Number:
`PCT/US2006/037078
`
`(22) International Filing Date:
`22 September 2006 (22.09.2006)
`
`(25) Filing Language:
`
`(26) Publication Language:
`
`English
`
`English
`
`(30) Priority Data:
`11/241,980
`11/296,216
`11/413,090
`
`4 October 2005 (04.10.2005)
`8 December 2005 (08.12.2005)
`28 April 2006 (28.04.2006)
`
`US
`US
`US
`
`(71) Applicant (for all designated States except US): ACETO
`AGRICULTURAL CHEMICALS CORPORATION
`[US/US]; One Hollow Lane, Lake Success, NY 11042
`(US).
`
`(72) Inventors; and
`(75) Inventors/Applicants (for US only): OLSON, Gary,
`Stephen [US/US]; 1988 Riting Court SE, Salem, OR
`97302 (US). SCHAFER, Ronald, K. [US/US]; 11254 Ca—
`mas, Boise, ID 83709 (US). GILLARD, Grace [GB/GB];
`16 Three Ways, Delarnere Park, Cuddington, Cheshire,
`CW8 2X] (GB).
`
` (10) International Publication Number
`
`WO 2007/044200 A2
`
`(74) Agents: TREANOR, Richard, L. et 31.; OBLON, SP1,
`VAK, MCCLELLAND, MAIER & NEUSTADT, PC,
`1940 Duke Street, Alexandria, VA 22314 (US).
`
`(81) Designated States (unless otherwise indicated, for every
`kind of national protection available): AE, AG, AL, AM,
`AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN,
`CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, Fl,
`GB, GD, GE, GH, GM, HN, HR, HU, ID, IL, IN, IS, JP,
`KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT,
`LU, LV, LY, MA, MD, MG, MK, MN, MW, MX, MY, MZ,
`NA, NG, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RS, RU,
`SC, SD, SE, SG, SK, SL, SM, SV, SY, Tl, TM, TN, TR,
`TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
`
`(84) Designated States (unless otherwise indicated, for every
`kind of regional protection available): ARIPO (BW, GH,
`GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM,
`ZW), Eurasian (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM),
`European (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, Fl,
`FR, GB, GR, HU, IE, IS, IT, LT, LU, LV, MC, NL, PL, PT,
`RO, SE, SI, SK, TR), OAPI (BF, BJ, CF, CG, CI, CM, GA,
`GN, GQ, GW, ML, MR, NE, SN, TD, TG).
`
`Published:
`
`* without international search report and to be republished
`upon receipt of that report
`
`For two-letter codes and other abbreviations, refer to the ”Guid-
`ance Notes on Codes and Abbreviations ” appearing at the begin-
`ning of each regular issue of the PCT Gazette.
`
`(54) Title: INHIBITION OF TUBER SPROUTING
`
`(57) Abstract: The present invention relates to inhibiting the sprouting of potato tubers using at least one of MCPP, carbetamide,
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, and MCPA, salts thereof and esters thereof.
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0001
`Page 0001
`
`
`
`02007/044200A2|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`. INHIBITION OF TUBER SPROUTING
`
`Reference to Related Applications
`
`This application is claims priority to US. application Serial No. 11/241,980
`
`filed October 4, 2005, to US. application Serial No. 11/296,216 filed December 8,
`
`2005, and to U.S. application Serial No. 11/413,090 filed April 28, 2006 ,all of
`
`which are incorporated herein in their entireties by reference.
`
`Field of the Invention
`
`The present invention relates to the use of at least one of MCPP,
`
`carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP,
`
`MCPA, their salts and esters, and mixtures thereof, to inhibit sprouting of tubers,
`
`particularly potato tubers, and most preferably the sprouting of tubers of stored
`
`potatoes. The application of at least one of MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, their salts and
`esters, and mixtures thereof, to tubers also makes up a part ofthe invention, as do
`
`tubers having at least one of MCPP, carbetamide, pronamide, ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, their salts and esters, and
`
`mixtures thereof on at least a part of a surface thereof. Salts and esters of these
`
`compounds can also be used in all aspects of the invention. Because potatoes are an
`
`important application of the present invention, they will be discussed in detail below.
`However, the invention is not limited thereto, and includes tubers in general such as
`
`other root crops like sweet potatoes and yams.
`
`Background of the Invention
`
`It is well known in the art to treat tubers such as potatoes with various
`
`chemicals having sprout-inhibiting properties. CIPC (chlorpropham, chlorprophame;
`
`chlor-IPC IUPAC name isopropyl 3-chlorocarbanilate; isopropyl 3-
`
`chlorophenylcarbamate;
`
`Chemical Abstracts name l-methylethyl (3-chlorophenyl)carbamate EEC no. 202-
`
`925-7) has been conventionally used for this purpose for about 40 plus years. More
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0002
`Page 0002
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`recently, chemicals such as various isomers of diisopropylnaphalene and other
`
`substituted naphthalenes have exhibited sprout-inhibiting characteristics.
`
`Potato tubers are often treated with a chemical sprout inhibitor in the storage
`
`season, and may receive another treatment of sprout inhibitor before being packaged
`
`for shipment to retail outlets. In the absence of chemical sprout inhibitors, the
`
`ultimate storage life is greatly reduced by loss of dormancy and early sprouting.
`
`Thus, virtually all potatoes stored mid and long term are treated with chemical
`
`sprout inhibitors.
`
`Potatoes when being dug are frequently bruised, cut and/or abraded. These
`
`injuries to the potatoes oftentimes cause spoilage during shipment, storage and the
`
`like. A process known as suberization occurs naturally which tends to heal many of
`
`these injuries. However, whenever potatoes are stored, which occurs with a
`
`particularly large portion of potatoes harvested in any given year, if healing occurs
`
`slowly, a significant loss of potatoes can occur through spoilage. Early treatment
`
`with certain sprout inhibitors, such as CIPC, may retard the suberization process,
`
`thus contributing to the loss of potatoes through spoilage.
`
`The main sprout inhibitors registered for use on potatoes are (CIPC), maleic
`
`hydrazide (MH), and dimethylnaphthalene (DMN) and Diisopropylnaphthalene
`
`(DIPN). The two chemicals in combination (CIPC plus DIPN) appear to be more
`
`effective at lower concentrations than either of the two chemicals alone.
`
`Simultaneous application of CIPC and DIPN provides improved results over
`
`application of either sprout inhibitors separately.
`
`For example, it is relatively common in the potato storage industry to treat
`
`potatoes with Chloroisopropyl-N—carbamate (CIPC) to prevent or retard
`
`development of sprouts in the potatoes. Even though untreated potatoes are stored at
`
`a cool temperature, for example, generally between about 36— 52 °F, sprouting does
`
`begin to occur after a month or more of storage. Storage of upwards of six to ten
`
`months is typical for stored potatos. Thus, without treatment of a chemical such as
`
`CIPC, the stored potatoes become entangled in sprouts and the whole stored lot of
`
`potatoes may become economically useless. Although early treatment with CIPC
`
`could be advantageous for sprout inhibition purposes, application of CIPC is
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0003
`Page 0003
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`typically delayed until after suberization has occurred inasmuch as CIPC tends to
`
`retard suberization, resulting in accelerated rot and spoilage.
`
`CIPC is typically applied in one or multiple applications to the tubers to be
`
`stored using thermal fogging techniques, sprays and powders. Conventional thermal
`
`fogging involving the application of CIPC into a stream of hot air or onto a hot
`
`surface of 550 -- 1000 °F, to produce a CIPC aerosol. The CIPC aerosol is circulated
`
`through potatoes piled in a potato storage building with the use of fans. Preferably
`
`the potatoes are turgid rather than soft when treated with the CIPC aerosol, since a
`
`pile of softened potatoes may be substantially compressed thereby impeding
`
`distribution of the aerosol. CIPC residue levels, will, however, typically decrease
`
`over time due to biodegration, venting and atmospheric loss. To extend the effective
`
`sprout inhibiting capability of CIPC, further applications may be needed.
`
`CIPC is used in significant quantities world wide and is capable of
`
`suppressing sprouts on stored tubers with the chemical ability to limit cell division.
`
`Increased rates, multiple applications, addition of substituted naphthalene
`
`chemistries coupled with strict storage management strategies have been
`implemented to help reduce sprout development in CIPC treated potatoes. The .
`
`instant invention provides an effective anti-sprouting treatment protocol that does
`
`not use CIPC and/or compliments the use of CIPC.
`
`Summa_ry of the Invention
`
`. The present invention embodies the inventors’ discovery that MCPP,
`
`carbetamide, pronamide (termed “propyzamide” in the UK), ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof, including
`
`the use of salts and esters thereof, inhibit the sprouting of tubers, particularly potato
`
`tubers, and that they can be used, if desired, in the same manner as conventional
`
`sprout inhibitors registered for use on potatoes. Of course, in addition to being used
`
`alone, MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4
`
`DB, 2,4 DP, MCPA, and mixtures thereof (including the use of salts and esters
`
`thereof) can be used in concert with any other sprout inhibitor(s). While certain of
`
`MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB,
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0004
`Page 0004
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`2,4 DP, MCPA, and mixtures thereof have been known for other uses, the inventors’
`
`discovery that MCPP, carbetamide, pronamide, ethofumesate, mefluidide,
`
`paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof, as well as salts and
`
`esters thereof, inhibit the sprouting of tubers represents a new use for these
`
`materials.
`
`Detailed Description of the Preferred Embodiments
`
`The active agents whose use in inhibiting the sprouting of tubers forms the
`
`basis of the present invention are known as MCPP, carbetamide, pronamide,
`
`ethofilmesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA. As explained
`
`further below, salts and esters thereof may also be used herein.
`
`MCPP:
`
`Other names for MCPP include Mecoprop, mechlorprop, mécoprop,
`
`Mecoprop-P, Kilprop, Mecopar, Triester-II, Mecomin-D, Mecopex, Mecomec, and
`
`U46 KV Fluid (41, 43), the technical brochures, data sheets, and MSDS sheets
`
`thereof all incorporated herein by reference. Preferred MCPP compounds useful
`
`herein include (RS)-2-(4—chloro-o-tolyloxy)propionic acid (i)-2-(4—chloro-2—
`
`methylphenoxy)propanoic acid, CAS RN [7085-19—0] racemate; [93-65—2]
`
`(formerly used for mecoprop) unstated stereochemistry Development Codes RD
`
`4593 (Boots); L143 (Marks), 2-(4—Chloro-o—tolyloxy) propionic acid otherwise
`
`known as 2—(4-Chloro-2-methylpheno;(y)propanoic acid. Compounds with CAS #5
`
`93-65—2 and 7085—19-0 are also preferred, as are (RS)—2—(4-chloro-0-
`
`tolyloxy)propionic acid, (R)-2-(4-Chloro-2-methylphenoxy)propionic acid and (S)-
`
`2-(4—Chloro-2—methylphenoxy)propionic acid. Also preferred are mecoprop-
`
`dimethylammonium [32351—70-5], mecoprop-diolamine [1432—14-0], mecoprop-
`ethadyl, mecoprop—isoctyl [28473-03-2], mecoprop-potassium [1929-86-8],
`
`mecoprop—sodium [19095-88-6], mecoprop—trolamine [53404-61-8]. A preferred
`
`MCPP compound for use in the present invention has the formula:
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0005
`Page 0005
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`Cl
`
`CH3
`CI
`A?
`l
`OMCH—C
`‘\
`OH
`
`CH3,
`
`Included are racemic mixtures and all stereoisomers (molecules that are identical in
`
`atomic constitution and bonding, but differ in the three-dimensional arrangement of
`
`the atoms) thereof, including individual enantiomers and mixtures thereof
`
`Similarly, all salts and esters of the above formula (including racemates and
`
`enantiomers thereof) and of all MCPP compounds are useful herein, especially the
`
`potassium, sodium and lithium salts thereof and the C1.-C24 esters thereof. As is
`
`known by those of skill in this art, the salts and esters of the above formula replace
`
`the hydrogen (H) of the hydroxyl group (—OH) with, e. g., a metal ion (e.g., Na+, K+,
`
`etc.) or, e.g., an alkyl group (e.g., -CI-I3), respectively. Preferred MCPP salts include
`
`the sodium and potassium salts. Preferred esters include C1-C24 branched or
`
`unbranched, substituted or unsubstituted alkyl and alkenyl esters, preferably C1-C10
`
`unbranched, Substituted or unsubstituted alkyl esters. "Substituted" refers to the
`
`replacement of hydrogen with a monovalent or divalent radical. Suitable
`
`substitution groups include, for example, hydroxyl, nitro, amino, imino, cyano, halo,
`
`thio, thioamido, amidino, imidino, 0X0, oxamidino, methoxamidino, imidino,
`
`guanidino, sulfonamido, carboxyl, formyl, loweralkyl, haloloweralkyl, loweralkoxy,
`
`haloloweralkoxy, loweralkoxyalkyl, alkylcarbonyl, arylcarbonyl, aralkylcarbonyl,
`
`heteroarylcarbonyl, heteroaralkylcarbonyl, alkylthio, aminoalkyl, cyanoalkyl, and
`
`the like.
`
`As used herein, the terms “MCPP” and “MCPP compound” include all of these
`
`materials including all acids, salts and esters thereof, particularly C1-C24 esters
`
`thereof. In Europe MCPP is sometimes referred to as “CMPP.” As used herein
`
`“MCPP” and “MCPP compound” include CMPP.
`
`Carbetamide:
`
`Carbetamide has the following structure:
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0006
`Page 0006
`
`

`

`WO 2007/044200
`
`PCT/USZOOG/037078
`
`and is variously known as (R)—1—(ethylcarbamoyl)ethyl carbanilate and (2R)—N—
`
`ethyl-Z—[[(phenylamino)carbonyl]oxy]propanamide. It has CAS No. 16118—49-3 and
`
`the empirical formula C12H16N203.
`
`Pronamide:
`
`Pronamide has the following structure:
`
`c1
`
`\‘ /
`
`m
`
`3H _
`3
`E
`
`got
`C
`x
`“swag—cam
`
`H
`
`CH3
`
`and is variously known as propyzamide, ,5—dichloro—N—(1,1—
`
`dimethylpropynyl)benzamide and 3,5-dichloro—N—(1 ,1 -dimethyl—2—
`
`propynyl)benzamide. It has CAS No. 23950—58—5 and the empirical formula
`
`C12H11C12N.
`
`Ethofumesate:
`
`Ethofumesate has the structure:
`
`G
`ll
`3143—3—13“
`ll
`0
`
`«('0
`
`CH1
`
`CHEW CH3
`/‘
`0
`CH3
`
`6
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0007
`Page 0007
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`and is variously known as (RS)—2—ethoxy-2,3—dihydro—3,3-dirnethylbenzofi1ran-S—y1
`
`methanesulfonate and 2-ethoxy—2,3—dihydro—3,3—dimethyl-5—benzofuranyl
`
`methanesulfonate. It has Registration No. 26225-79—6 and an empirical formula
`
`C13H18058.
`
`Mefluidide:
`
`Mefluidide has the structure:
`
`
`
`and is variously known as 5’—(l,1,1~trifluoromethanesulfonamido)acet—2’,4’-xy1idide
`
`and N— [2,4-dimethyl-5—[[(trifluoromethyl)sulfonyl]amino]phenyl]acetamide. It has
`
`CAS No. 53780—34—0 and empirical formula C11H13F3N203S.
`
`Paclobutrazol:
`
`Paclobutrazol has the structure:
`
`CH3
`
`KNR
`
`a
`
`I
`
`H C—E—CR
`
`:2
`
`Nfi-fiHmflH—DH
`NW
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0008
`Page 0008
`
`(3H2
`
`\ C
`
`l
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`and is variously known as (ZRS, 3RS)-l-(4-chlorophenyl)—4,4-dimethyl-2-(1H-l,2,4-
`
`triazol— l -y1)pentan-3—ol and el—(dR,[3R)-[3-[(4-chlorophenyl)methyl] -0L—(1 , 1 -
`
`dimethylethyl)-1H-1,2,4-triazole—1-ethanol. It has Registration No. 7673 8-62-0 and
`
`the empirical formula C15H20C1N30.
`
`2,4 DB:
`
`2,4 DB has the structure:
`
`Cl
`
`(:1
`
`C}
`it
`
`0H
`
`It is variously known as 4—(2,4—dichlorophenoxy)butyric acid and 4-(2,4-
`
`dichlorophenoxy)butanoic acid. It has CAS No. 94—82—6 and the empirical formula
`
`C10H1001203, This material can be used as a salt, or an ester, such as 2,4-DB-butyl,
`
`2,4-DB-dimethylammonium [275 8—42—1], 2,4-DB-isoctyl, 2,4-DB-potassium
`
`[19480-40—1], 2,4—DB-sodium [10433—59—7], etc.
`
`2,4 DP:
`
`2,4 DP has the structure:
`
`Cl
`
`.
`
`c1
`
`CH3
`l
`
`CI-eCH-Ci
`
`0
`
`I
`
`DH
`
`It is variously known as (RS)-2-(2,4—dichlorophenoxy)propionic acid and 2-(2,4—
`dichlorophenoxy)propanoic acid. It has CAS No. 120-36-5 and the empirical
`formula CgHgCIZO3, This material can be used as a salt, or an ester, such as ’
`
`dichlorprop—butotyl, dichlorprop—dimethylammonium, dichlorprop—ethylammonium,
`
`dichlorprop—isoctyl [28631—35-8], dichlorprop-potassium. The (R)—isomer of this
`
`substance has the common name dichlorprop—P.
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0009
`Page 0009
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`MCPA:
`
`MCPA has the general structure:
`
`Cl
`
`It is variously known as (4—chloro—2-methylphenoxy)acetic acid and 4—chloro—o-
`
`tolyloxyacetic acid. It has CAS No. 94—74—6 and the empirical formula C9H9C103,
`
`The name “metaxon” was used in the former USSR. This material can be used as a
`
`salt, or an ester, such as for example MCPA—butotyl [19480—43—4], MCPA—butyl
`
`[1713 —12—8], MCPA-dimethylammonium [2039—46—5] , MCPA—diolamine [20405 -
`
`19-0], MCPA-2—ethylhexyl [29450—45— 1], MCPA—isobutyl [1713-1 1-7], MCPA-
`
`isoctyl [26544-20-7], MCPA-isopropyl [2698—40—0], MCPA-methyl [2436—73—9],
`MCPA—olamine [6365-62-4], MCPA—potassium [52217l6-9], MCPA—sodium [3653-
`
`48-3], MCPA—trolamine [4245 9-68-7].
`
`Included as useful herein for all of MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures
`
`thereof, are racemic mixtures and all stereoisomers (molecules that are identical in
`
`atomic constitution and bonding, but differ in the three—dimensional arrangement of
`
`the atoms) thereof, including individual enantiomers and mixtures thereof.
`
`Similarly, all salts and esters of the above formulae (including racemates and
`
`enantiomers thereof) are useful herein, especially the potassium, sodium and lithium
`
`salts thereof and the C1-C24 esters thereof. As is known by those of skill in this art,
`
`the salts and esters of the above formula replace, e. g.,
`
`the hydrogen (H) of the
`
`hydroxyl group (—OH) with, e.g., a metal ion (e. g., Na+, K+, etc.) or a
`
`dimethylamine group, etc., or a carbonylhydrocarbon group (COR) or, for MCPP,
`
`2,4 DB 2,4-DP and MCPA, e.g., a hydrocarbon group such as an alkyl group (e.g., ~
`
`CH3), respectively. Alternatively, or in addition, salts may be formed at the nitrogen
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0010
`Page 0010
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`atom by addition, of, e. g., acids, etc. Those of skill in this art are aware of where
`
`and how salts and esters of the noted compounds herein can be made and used in
`
`View of this disclosure. Preferred salts include the sodium and potassium salts as
`
`well as the hydrohalide salts such as hydrochloride, etc. Preferred esters include Cl-
`
`C24 branched or unbranched, substituted or unsubstituted alkyl and alkenyl esters,
`
`preferably 01—010 unbranched, substituted or unsubstituted alkyl esters.
`
`"Substituted" refers to the replacement of hydrogen with a monovalent or divalent
`
`radical. Suitable substitution groups include, for example, hydroxyl, nitro, amino,
`
`imino, cyano, halo, thio, thioamido, amidino, imidino, oxo, oxamidino,
`
`methoxamidino, imidino, guanidino, sulfonamido, carboxyl, formyl, loweralkyl,
`
`haloloweralkyl, loweralkoxy, haloloweralkoxy, loweralkoxyalkyl, alkylcarbonyl,
`arylcarbonyl, aralkylcarbonyl, heteroarylcarbonyl, heteroaralkylcarbonyl, alkylthio,
`
`aminoalkyl, cyanoalkyl, and the like.
`
`As used herein, the term “tuber” is inclusive of "potato tuber." "Potato tuber“
`
`refers to the underground storage organ of the potato plant (Solanum tuberosum).
`
`The potato tuber is a modified stem and includes buds that can sprout and form new
`
`potato plants. The term “(potato) tubers” refers to both tubers generally and to
`
`potato tubers. Preferred potatoes include Russet Burbank, Ranger Russet, Umatilla
`
`Russet, Shepody, Norkotah Russet, Yukon Gold, Norchip, Gem Russet, Atlantic,
`
`Chipeta, Snowden, and Dark Red Norland
`
`The phrase "effective to inhibit sprouting" means that: (a) the number,
`
`and/or the weight, of stems (sprouts) growing from a defined number of (potato)
`
`tubers contacted with at least one of MCPP, carbetamide, pronamide, ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof, salts and
`
`esters thereof, in accordance with the present invention is less than the number,
`
`and/or the weight, of stems growing from the same number of control (potato)
`
`tubers (of the same cultivar as the treated (potato) tubers) that were not contacted
`
`with a sprouting inhibitor; and/or (b) the average rate of growth of stems growing
`
`from a defined number of (potato) tubers contacted with at least one of MCPP,
`
`carbetamide, pronamide, ethofumesate, mefluidide, pac‘lobutrazol, 2,4 DB, 2,4 DP,
`
`MCPA, and mixtures thereof, salts and esters thereof, in accordance with the present
`
`invention is less than the average rate of growth of stems growing from the same
`
`10
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0011
`Page 0011
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`number of control (potato) tubers (of the same cultivar as the treated (potato) tubers)
`
`that were not contacted with a sprouting inhibitor. Such inhibition can be at any
`
`time as compared to the control. As understood by those in this field, the concept of
`
`inhibition is meaningful when control tubers show activity being inhibited in tubers
`
`contacted with at least one of MCPP, carbetamide, pronamide, ethofumesate,
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof, salts and
`
`esters thereof. Another preferred measure of inhibition is a comparison between the
`
`total amount of “dormant + sprout up to 3 mm” tubers at, e.g., 50 days after harvest
`
`as compared to untreated control. Whichever measure is used, preferred amounts of
`
`inhibition include less than 1%, 1%, 3%, greater than 3%, 5%, 8%, 10%, 20%,
`
`30%,etc. to 100%.
`
`As used herein the phrase “at least one of MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures
`
`thereof” includes salts and esters thereof, and any mention of an invention
`
`compound or material (e.g., carbetamide) herein includes its salts, and includes its
`
`salts and esters for any invention compound capable of forming a salt ans/or an ester
`
`such as MCPP, paclobutrazol, 2,4 DB, 2,4 DP, and MCPA.
`
`The MCPP, carbetamide, pronamide, ethofumesate, mefluidide,
`
`paclobutrazol, 2,4 DB, 2,4 DP, and MCPA materials, salts and esters thereof, used
`
`herein can be purchased commercially, or synthesized by one of ordinary skill in the
`
`art. They can be used alone or in mixture, and can be applied together with other
`
`materials such as other sprout inhibitors. By “together,” we mean that the MCPP,
`
`carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP,
`
`MCPA, and mixtures thereof can be used in mixture with other materials such as
`
`active agents upon application to, e. g., potatoes, and/or can be used sequentially
`
`before, during, and/or after application of any other material. Useful combinations
`
`of MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4
`
`DB, 2,4 DP, MCPA, and mixtures thereof with other materials include combinations
`
`with one or more of MCPP, MCPA, CIPC, 2,4-D and dicamba. However,
`
`formulations including dicamba are not preferred due to the long residual of
`
`dicamba and the harmful effects that minute residues of dicamba cause in potato.
`
`Potatoes treated with dicamba or the surfaces contacted by these potatoes can render
`
`11
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0012
`Page 0012
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`the storage and handling equipment trucks and such unfit for handing seed potatoes.
`
`In addition, and regardless whether MCPP, carbetamide, pronamide, ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof are utilized
`
`with any other active agent, the present invention includes multiple applications of
`
`MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB,
`
`2,4 DP, MCPA, and mixtures thereof on the same tuber, generally where the
`
`applications are spaced over certain time intervals.
`
`In general, the present invention includes any application of MCPP,
`
`carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP,
`
`MCPA, and mixtures thereof to tubers, and particularly includes application to
`
`potato plants in the field before the potatoes are harvested, and/or application after
`
`the potatoes are harvested but before they are stored, and/or application after the
`
`potatoes are in storage. In a preferred embodiment the MCPP, carbetamide,
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and
`
`mixtures thereof is applied Via an aerosol, spray or thermal fog, as a dust, or in
`
`microencapsulated form to harvested potatoes. Methods of application also include
`
`via aerosol can and via smoke generators, for example for treatment in rail cars.
`
`MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB,
`
`2,4 DP, MCPA, and mixtures thereof may also be first or subsequently applied after
`
`tubers (potatoes) have been harvested and stored for a sufficient period that bruises
`
`and cuts have healed, i.e., suberization has occurred. In another aspect of the
`
`invention, the MCPP, carbetamide, pronamide, ethofumesate, mefluidide,
`
`paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof is applied such that it
`
`inhibits sprouting during the potato shipping and distribution process.
`
`In accordance with the foregoing, the present invention provides methods for
`
`inhibiting sprouting of potato tubers, the methods each including the step of
`
`contacting a potato tuber with an amount of at least one of MCPP, carbetamide,
`
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and
`
`mixtures thereof, wherein the amount of the at least one carbetamide, pronamide,
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA is effective to
`
`inhibit potato tuber sprouting. Typically, the at least one MCPP, carbetamide,
`
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, is
`
`12
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0013
`Page 0013
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`applied simultaneously, or substantially simultaneously, to numerous, harvested,
`
`potato tubers. In the practice of the methods of the invention the at least one of
`
`MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB,
`
`2,4 DP, MCPA is applied after the potato tubers have been harvested, but typically
`
`not later than the onset of sprouting. In some embodiments of the methods of the
`
`invention, the effective amount of at least one MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA is that amount
`
`sufficient to provide a dosage of from far less than 1 mg per/ 1 kg (parts per million)
`
`potato tubers to, e. g., 100 ppm, 500 ppm, and above. Preferred amounts include 0.01,
`
`0.05, 0.1, 0.2, 0.3, 0.5, 1, 2, 3, 5, 8, 10, 15, 20, 25, 30, 35, 40, 50, 60, etc. ppm.
`
`The instant invention includes a method of inhibiting the sprouting of stored
`
`tubers, especially potatoes, by applying a first sprout inhibiting chemical to the
`
`stored potatoes and then applying a second sprout inhibiting chemical at a later time,
`
`where at least one of the sprout inhibiting chemicals is at least one of MCPP,
`carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP,
`
`MCPA. Because multiple applications of MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures
`
`thereof makes up a part of the invention, the “second sprout inhibiting chemical”
`
`can be any of MCPP, carbetamide, pronamide, ethofumesate, mefluidide,
`paclobutrazol, 2,4 DB, 2,4 DP, MCPA, and mixtures thereof. Other useful sprout
`inhibitors include CIPC, MCPP, and DMN (dimethyl naphthalene) or DIPN,
`
`especially 2,6 Disopropyl naphthalene. Multiple materials may be applied together,
`
`or the time elapsed between application of the first and second chemical
`
`applications may be from a few moments to several months. The second chemical is
`
`generally applied at a time span when the efficacy of the sprout inhibiting
`
`characteristics of the first chemical is waning. Application may be in any fashion,
`
`and may be according to the methods detailed in any of U.S.
`
`4226179, 6432882, 6790469, 6855669, 6310004, 6107247, 6010728, 6001773,
`
`5965489, 5436226, 5,622,912 , 5,811,372, and 6855669 all incorporated herein by
`
`reference.
`
`In accordance with the foregoing, in one aspect, the present invention
`
`provides methods for treating (potato) tubers, the methods each comprising the step
`
`13
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0014
`Page 0014
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`of contacting a (potato) tuber with an amount of at least one of MCPP, carbetamide,
`
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP and MCPA.
`
`Preferably the amount of the at least one of MCPP, carbetamide, pronamide,
`
`ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP and MCPA is an amount
`
`effective to inhibit (potato) tuber sprouting. However, this is not required. For
`
`example, when the at least one of MCPP, carbetamide, pronamide, ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP and MCPA is used together with another
`
`sprout inhibitor, the at least one MCPP, carbetamide, pronamide, ethofumesate,
`
`mefluidide, paclobutrazol, 2,4 DB, 2,4 DP and MCPA can be used in an amount less
`
`than that effective to inhibit potato tuber sprouting. Preferably, of course, the total
`
`amount of sprout inhibitor (i.e., the amount of the at least one of MCPP,
`
`carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP,
`
`and MCPA compound, mixture thereof, and any additional sprout inhibitor(s)) is
`
`effective to inhibit potato tuber sprouting. Such additional sprout inhibitors include,
`
`e. g. CIPC, MCPP, chlorpropham, maleic hydrazide, diisopropylnaphthalene,
`
`dimethylnaphthalene, carvone, aliphatic aldehydes and ketones, eugenol,
`
`benzothiazide, ethylene, aromatic acids (e.g., anisic acid, coumaric acid, gallic acid),
`
`rape oil methyl ester, medium and long-chain alcohols, jasmonates, aromatic
`
`aldehydes (e.g., benzaldehyde, salicaldehyde, cinnamaldehyde,
`
`hydrocinnamaldehyde, cuminaldehyde, thymol), monoterpenes (e.g., cineole,
`
`fenchone, menthol), and essential oils (e.g., mint oils)). In addition, sprout inhibitors
`
`listed in the following US patents, all incorporated herein by reference, may be used:
`
`6,958,167
`
`6,946,155
`
`6,855,669
`
`6,790,469
`
`6,541,054
`
`6,495,710
`
`6,432,882
`
`6,403,536
`
`6,375,999
`
`6,338,296
`
`6,322,002
`
`6,310,004
`
`6,107,247
`
`6,068,888
`
`14
`
`1,4 GROUP, INC.
`1,4 GROUP, INC.
`Exhibit 1005
`Exhibit 1005
`Page 0015
`Page 0015
`
`

`

`WO 2007/044200
`
`PCT/U82006/037078
`
`6,010,728
`
`6,001,773
`
`5,965,489
`
`5,935,660
`
`5,918,537
`
`5,849,664
`
`5,580,596
`
`5,436,226
`
`5,009,152
`
`4,977,825
`
`4,887,525
`
`4,226,179
`
`Where a combination of sprout inhibitors is applied in a single composition it is
`
`preferred that the composition comprise A) at least one of MCPP, carbetamide,
`
`pronamide, ethofumesate, mefluidide, paclobutrazol, 2,4 DB, 2,4 DP and MCPA
`
`and, further, B) at least one other sprout inhibitor, such as CIPC. The weight ratio of
`
`A/B can vary Without limitation, and is preferably 99/1, 95/5, 90/10, 85/15, 80/20,
`
`75/25, 70/30, 65/35, 60/40, 55/45, 50/50, 45/55, 40/60, 35/65, 30/70, 25/75, 20/80,
`
`15/85, 10/90, 5/95, 1/99, etc., including all values and subranges between less than
`
`100 and greater than 0. Preferably, the amount of sprout inhibitor applied, in ppm,
`
`has these same values and, for example, include A/B ratios such as 121.1, 1:4.4, ,
`
`1:11, etc. A preferred example is the application of, e.g., 10 ppm MCPP + 11 ppm
`
`CIPC, 1 ppm MCPP + 11 ppm CIPC, etc. Where multiple sprout inhibitors are
`
`applied, Whether simultaneously from the same or different compositions or applied
`
`in a time separated manner, useful amounts of the inhibitor(s) according the
`
`invention (MCPP, carbetamide, pronamide, ethofumesate, mefluidide, paclobutrazol,
`
`2,4 DB, 2,4 DP, MCPA, and mixtures thereof) and of another inhibitor or inhibitors
`
`(Inhibitor X) include less than 1, 1, 3, 5, 8, 10, 15, 18, 20, 30, 40, 50, 70, 90, 100,
`
`120, 150, 1

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket